BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2846575)

  • 41. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
    Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
    Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular characteristics and evidence for internalization of vasoactive-intestinal-peptide (VIP) receptors in the tumoral rat-pancreatic acinar cell line AR 4-2 J.
    Svoboda M; De Neef P; Tastenoy M; Christophe J
    Eur J Biochem; 1988 Oct; 176(3):707-13. PubMed ID: 2844535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The human vasoactive intestinal peptide receptor: molecular identification by covalent cross-linking in colonic epithelium.
    Couvineau A; Laburthe M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):50-5. PubMed ID: 2987295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature.
    el Battari A; Luis J; Martin JM; Fantini J; Muller JM; Marvaldi J; Pichon J
    Biochem J; 1987 Feb; 242(1):185-91. PubMed ID: 3036083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined ultrastructural and biochemical study of cellular processing of vasoactive intestinal peptide and its receptors in human colonic carcinoma cells in culture.
    Hejblum G; Gali P; Boissard C; Astesano A; Marie JC; Anteunis A; Hui Bon Hoa D; Rosselin G
    Cancer Res; 1988 Nov; 48(21):6201-10. PubMed ID: 2844402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
    Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
    Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
    Wanke IE; Rorstad OP
    Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
    Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE
    J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking. Evidence for two classes of binding sites with different structural and functional properties.
    Laburthe M; Breant B; Rouyer-Fessard C
    Eur J Biochem; 1984 Feb; 139(1):181-7. PubMed ID: 6321173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells.
    Frucht H; Gazdar AF; Park JA; Oie H; Jensen RT
    Cancer Res; 1992 Mar; 52(5):1114-22. PubMed ID: 1310640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of covalent VIP-receptor complexes in intestinal cell membranes.
    Robichon A; Marie JC
    Endocrinology; 1987 Mar; 120(3):978-85. PubMed ID: 3026793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular characterization and peptide specificity of two vasoactive intestinal peptide (VIP) binding sites in the chicken pineal.
    Meunier AC; Voisin P; Van Camp G; Cenatiempo Y; Muller JM
    Neuropeptides; 1991 May; 19(1):1-8. PubMed ID: 1653910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
    Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
    Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor.
    Couvineau A; Laburthe M
    Biochem J; 1985 Jan; 225(2):473-9. PubMed ID: 3977841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoradiographic localization of vasoactive intestinal polypeptide receptors in the rat mesenteric vascular tree.
    Amenta F; Cavallotti C; Collier WL; Ferrante F; Geppetti P; Ricci A
    Regul Pept; 1989 Aug; 26(1):9-17. PubMed ID: 2554372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of vasoactive intestinal peptide receptors in retina.
    Swedlund AP; Rosenzweig SA
    Exp Eye Res; 1990 Sep; 51(3):317-23. PubMed ID: 2169429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase.
    Besson J; Malassiné A; Ferré F
    Regul Pept; 1987 Nov; 19(3-4):197-207. PubMed ID: 2829291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.